Prevention of rabbit acute lung injury by surfactant, inhaled nitric oxide, and pressure support ventilation

被引:59
作者
Zhou, ZH
Sun, B
Lin, K
Zhu, LW
机构
[1] Shanghai Med Univ, Childrens Hosp, Res Inst, Shanghai 200032, Peoples R China
[2] Shanghai Shen Ning Inst Appl Biochem, Shanghai, Peoples R China
关键词
D O I
10.1164/ajrccm.161.2.9901048
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Improvement of pulmonary perfusion and blood oxygenation and prevention of acute lung injury (ALI) may rely on ventilation strategy. We hypothesized that application of a combined surfactant, inhaled nitric oxide (iNO), and pressure support ventilation (PSV) should more effectively protect the lungs from injury. Anesthetized and intubated adult rabbits weighing 2.8 +/- 0.3 kg were allowed to breathe room air while receiving oleic acid intravenously (60 mu l/kg). Within 90 min this caused a reduction of Pa-O2 from 94 +/- 7 to 48 +/- 3 mm Hg and dynamic lung compliance (Cdyn) from 1.59 +/- 0.22 to 0.85 +/- 0.10 ml/cm H2O/kg (both p < 0.01), and increase of intrapulmonary shunting ((Q) over dot s/(Q) over dot T) from 9.4 +/- 1.2 to 27 +/- 5% (p < 0.05). PSV was subsequently applied with 3 cm H2O of continuous positive airway pressure and FIO2 of 0.3, and the animals were randomly allocated to four groups, receiving: (1) PSV only (Control, n = 10); (2) iNO at 20 ppm (NO, n = 9); (3) surfactant phospholipids at 100 mg/kg (Surf, n = 8); and (4) surfactant at 100 mg/kg and iNO at 20 ppm (SNO, n = 8). PSV level was varied to maintain a tidal volume of 8 to 10 ml/kg for another 12 h or until early animal death. Five animals in the SNO, three each in the NO and Surf group, and one in the Control group survived 12 h (SNO versus Control, p < 0.05). The NO, Surf, and SNO groups had significantly improved mean Pa-O2 (> 70 mm Hg, p < 0.05), and reduced (Q) over dot s/(Q) over dot T (15, 19, and 17%, respectively, p < 0.05) at 6 and 12 h, but not in the Control group. The SNO group had the highest values of Cdyn at 12 h, alveolar aeration and disaturated phosphatidylcholine-to-total protein ratio in bronchoalveolar lavage fluid, and the lowest wet-to-dry lung weight ratio and lung injury score (p < 0.05). The results indicate that early alleviation of ALI by surfactant, iNO, and PSV is due to synergistic effects, and only PSV in this model had limited effects.
引用
收藏
页码:581 / 588
页数:8
相关论文
共 28 条
  • [1] The American-European Consensus Conference on ARDS, Part 2 - Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling
    Artigas, A
    Bernard, GR
    Carlet, J
    Dreyfuss, D
    Gattinoni, L
    Hudson, L
    Lamy, M
    Marini, JJ
    Matthay, MA
    Pinsky, MR
    Spragg, R
    Suter, PM
    Blanch, L
    Burchardi, H
    Hedenstierna, C
    Lemaire, F
    Roussos, C
    Mancebo, J
    Morris, A
    Pesenti, A
    Rossi, A
    Van Asbeck, BS
    Brigham, KL
    Dhainaut, JF
    Fowler, AA
    Hyers, TM
    Morel, D
    Rodriguez-Roisin, R
    Schaller, MD
    Hemmer, M
    Torres, A
    Villar, J
    Vincent, JL
    Leeper, K
    Meyrick, B
    Oppenheimer, L
    Reid, L
    Murray, JF
    Bihari, D
    Bosken, C
    Goris, J
    Johanson, WJ
    Lanken, PN
    Le Gall, JR
    Morris, AH
    Rinaldo, J
    Pattishal, EN
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (04) : 1332 - 1347
  • [2] BARTLETT GR, 1959, J BIOL CHEM, V234, P466
  • [3] THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION
    BERNARD, GR
    ARTIGAS, A
    BRIGHAM, KL
    CARLET, J
    FALKE, K
    HUDSON, L
    LAMY, M
    LEGALL, JR
    MORRIS, A
    SPRAGG, R
    COCHIN, B
    LANKEN, PN
    LEEPER, KV
    MARINI, J
    MURRAY, JF
    OPPENHEIMER, L
    PESENTI, A
    REID, L
    RINALDO, J
    VILLAR, J
    VANASBECK, BS
    DHAINAUT, JF
    MANCEBO, J
    MATTHAY, M
    MEYRICK, B
    PAYEN, D
    PERRET, C
    FOWLER, AA
    SCHALLER, MD
    HUDSON, LD
    HYERS, T
    KNAUS, W
    MATTHAY, R
    PINSKY, M
    BONE, RC
    BOSKEN, C
    JOHANSON, WG
    LEWANDOWSKI, K
    REPINE, J
    RODRIGUEZROISIN, R
    ROUSSOS, C
    ANTONELLI, MA
    BELOUCIF, S
    BIHARI, D
    BURCHARDI, H
    LEMAIRE, F
    MONTRAVERS, P
    PETTY, TL
    ROBOTHAM, J
    ZAPOL, W
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) : 818 - 824
  • [4] Inhaled nitric oxide in children with severe lung disease: Results of acute and prolonged therapy with two concentrations
    Day, RW
    Guarin, M
    Lynch, JM
    Vernon, DD
    Dean, JM
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (02) : 215 - 221
  • [5] Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial
    Dellinger, RP
    Zimmerman, JL
    Taylor, RW
    Straube, RC
    Hauser, DL
    Criner, GJ
    Davis, K
    Hyers, TM
    Papadakos, P
    [J]. CRITICAL CARE MEDICINE, 1998, 26 (01) : 15 - 23
  • [6] INACTIVATION OF EXOGENOUS SURFACTANT IN EXPERIMENTAL RESPIRATORY-FAILURE INDUCED BY HYPEROXIA
    ENNEMA, JJ
    KOBAYASHI, T
    ROBERTSON, B
    CURSTEDT, T
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1988, 32 (08) : 665 - 671
  • [7] Bovine surfactant therapy for patients with acute respiratory distress syndrome
    Gregory, TJ
    Steinberg, KP
    Spragg, R
    Gadek, JE
    Hyers, TM
    Longmore, WJ
    Moxley, MA
    Cai, GZ
    Hite, RD
    Smith, RM
    Hudson, LD
    Crim, C
    Newton, P
    Mitchell, BR
    Gold, AJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (04) : 1309 - 1315
  • [8] EVIDENCE OF LUNG SURFACTANT ABNORMALITY IN RESPIRATORY-FAILURE - STUDY OF BRONCHOALVEOLAR LAVAGE PHOSPHOLIPIDS, SURFACE-ACTIVITY, PHOSPHOLIPASE-ACTIVITY, AND PLASMA MYOINOSITOL
    HALLMAN, M
    SPRAGG, R
    HARRELL, JH
    MOSER, KM
    GLUCK, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (03) : 673 - 683
  • [9] SENSITIVE MICROMETHOD FOR DETERMINATION OF METHEMOGLOBIN IN BLOOD
    HEGESH, E
    GRUENER, N
    COHEN, S
    BOCHKOVSKY, R
    SHUVAL, HI
    [J]. CLINICA CHIMICA ACTA, 1970, 30 (03) : 679 - +
  • [10] The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema
    Hoffmann, B
    Welte, T
    [J]. INTENSIVE CARE MEDICINE, 1999, 25 (01) : 15 - 20